…
Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ramsay Health Care is a multinational private hospital operator delivering acute, surgical and ancillary health services through a network of hospitals and clinics. Long-term growth may be supported by aging populations and rising demand for elective and specialist procedures, together with organic capacity growth and selective acquisitions. Investors may find the company attractive for its scale, recurring inpatient and outpatient revenue streams and exposure to defensive healthcare demand.
Key risks include exposure to regulatory and reimbursement changes, cost and staffing pressures that can compress margins, and execution and integration risk from expansion into new markets.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | 513.60M | 101.80M | 384.60M | 527.10M | 538.50M |
| Minority interest | - | -22.30M | 7.30M | -67.40M | -105.20M |
| Net income | 329.20M | 24.00M | 888.70M | 298.10M | 274.00M |
| Selling general administrative | - | 11040.20M | 10323.50M | 9431.00M | 8309.50M |
| Selling and marketing expenses | - | - | 9649.70M | - | - |
| Gross profit | 1772.40M | 2115.20M | 1610.70M | 11515.30M | 9974.30M |
| Reconciled depreciation | - | 1126.30M | 1082.10M | 989.10M | 927.60M |
| Ebit | 1014.90M | 1034.30M | 724.10M | 800.00M | 696.60M |
| Ebitda | 2196.10M | 1592.80M | 1806.20M | 1789.10M | 1624.20M |
| Depreciation and amortization | 1181.20M | 558.50M | 1082.10M | 989.10M | 927.60M |
| Operating income | 1014.90M | 2115.20M | 936.90M | 660.30M | 460.90M |
| Other operating expenses | 17562.90M | 15676.40M | 15727.00M | 12671.70M | 11411.40M |
| Interest expense | 608.40M | 621.80M | 620.00M | 261.20M | 146.80M |
| Tax provision | - | 55.50M | 121.30M | 181.50M | 159.30M |
| Interest income | - | 17.40M | 7.00M | 514.30M | 36.20M |
| Net interest income | - | -604.40M | -613.00M | -474.30M | -352.80M |
| Extraordinary items | - | 0.00M | 618.10M | 19.90M | 8.10M |
| Income tax expense | 192.20M | 55.50M | 121.30M | 181.50M | 159.30M |
| Total revenue | 18577.80M | 17791.60M | 16660.20M | 14863.00M | 13082.10M |
| Total operating expenses | 757.50M | 728.50M | 12013.60M | 10961.10M | 9743.70M |
| Cost of revenue | 16805.40M | 15676.40M | 3713.40M | 3347.70M | 3107.80M |
| Total other income expense net | -501.30M | -2013.40M | -552.30M | 447.20M | 660.70M |
| Discontinued operations | - | - | - | 19.90M | 15.30M |
| Net income from continuing ops | - | 46.30M | 263.30M | 345.60M | 379.20M |
| Net income applicable to common shares | - | 6.80M | 872.00M | 285.10M | 265.00M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 21170.20M | 22475.50M | 21342.40M | 21030.20M | 19473.30M |
| Intangible assets | 398.30M | 424.90M | - | 407.30M | 435.20M |
| Other current assets | 290.30M | 48.80M | 308.50M | 28.30M | 24.50M |
| Total liab | 15576.40M | 16766.80M | 15814.90M | 16207.00M | 14947.10M |
| Total stockholder equity | 4956.00M | 5023.60M | 4897.60M | 4154.80M | 3933.50M |
| Other current liab | 2005.20M | - | 1827.20M | 2326.10M | 2264.10M |
| Common stock | 2285.90M | - | 2246.80M | 2148.60M | 2125.20M |
| Capital stock | - | 2482.40M | - | 2400.80M | 2377.40M |
| Retained earnings | 2457.30M | 2328.70M | 2500.20M | 1786.70M | 1708.70M |
| Other liab | - | - | - | 997.10M | 920.40M |
| Good will | 5577.20M | 6006.20M | 5744.90M | 5756.40M | 5363.80M |
| Other assets | - | - | - | 719.00M | 669.20M |
| Cash | 729.90M | 784.40M | 662.30M | 656.10M | 314.20M |
| Cash and equivalents | - | - | - | - | 314.20M |
| Total current liabilities | 4065.70M | 4465.60M | 4180.30M | 3810.40M | 3725.60M |
| Current deferred revenue | - | - | 95.60M | -486.80M | -412.10M |
| Net debt | 10268.60M | 4752.50M | 10275.80M | 11230.20M | 10384.50M |
| Short term debt | 628.30M | - | 605.70M | 486.80M | 397.60M |
| Short long term debt | - | 78.50M | - | 69.90M | 42.80M |
| Short long term debt total | 10998.50M | - | 10938.10M | 11886.30M | 10698.70M |
| Other stockholder equity | -39.40M | - | 2183.80M | -4003.10M | -3906.30M |
| Property plant equipment | - | - | - | 10187.20M | 9434.60M |
| Total current assets | 3704.90M | 4040.30M | 3872.80M | 3895.80M | 3286.70M |
| Long term investments | - | 110.80M | - | 83.60M | 338.90M |
| Net tangible assets | - | - | - | -2261.10M | -2117.70M |
| Short term investments | - | - | - | 64.50M | 11.30M |
| Net receivables | 2281.50M | 2701.50M | 2522.60M | 2266.90M | 2331.30M |
| Long term debt | - | 5458.40M | - | 5861.50M | 5173.50M |
| Inventory | 403.20M | 404.40M | 379.40M | 388.60M | 376.80M |
| Accounts payable | 1432.20M | 1728.10M | 1651.80M | 1484.30M | 1476.00M |
| Accumulated other comprehensive income | - | - | -2285.40M | -32.70M | -152.60M |
| Non currrent assets other | 132.20M | 10.40M | 475.70M | 256.20M | 135.40M |
| Non current assets total | 17465.30M | 18435.20M | 17469.60M | 17134.40M | 16186.60M |
| Capital lease obligations | - | 6583.00M | - | 5954.90M | 5482.40M |
| Long term debt total | - | - | - | - | 10301.10M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -765.30M | 159.70M | -713.80M | 30.00M |
| Change to liabilities | - | - | - | 102.80M | 124.70M |
| Total cashflows from investing activities | -675.00M | -765.30M | 159.70M | -713.80M | 30.00M |
| Net borrowings | - | 93.20M | -825.40M | -3.60M | -1037.80M |
| Total cash from financing activities | -789.00M | -631.20M | -1450.10M | -242.40M | -1410.90M |
| Change to operating activities | - | - | - | -89.20M | -31.80M |
| Net income | 329.20M | 24.00M | 270.60M | 298.10M | 274.00M |
| Change in cash | -54.50M | 122.10M | 6.20M | 341.90M | -690.60M |
| Begin period cash flow | 784.40M | 662.30M | 656.10M | 314.20M | 1004.80M |
| End period cash flow | 729.90M | 784.40M | 662.30M | 656.10M | 314.20M |
| Total cash from operating activities | 1442.10M | 1480.80M | 1292.80M | 1279.60M | 715.50M |
| Depreciation | 1181.20M | 1126.30M | 1082.10M | 962.30M | 906.90M |
| Other cashflows from investing activities | 62.30M | 36.90M | 16.10M | 7.10M | 1972.20M |
| Dividends paid | 205.70M | -161.60M | -158.30M | -236.80M | -371.00M |
| Change to inventory | -20.80M | -4.20M | 17.50M | -14.20M | 28.20M |
| Change to account receivables | 65.00M | 157.90M | -264.50M | 118.20M | -664.80M |
| Other cashflows from financing activities | -632.00M | -54.00M | -466.40M | 2463.60M | 4733.50M |
| Change to netincome | - | - | - | -32.20M | 72.70M |
| Capital expenditures | 734.20M | 776.60M | 753.80M | 720.90M | 708.50M |
| Change in working capital | -36.70M | 56.00M | -48.70M | 104.00M | -636.60M |
| Stock based compensation | - | 10.70M | - | 8.00M | 13.00M |
| Other non cash items | -31.60M | 263.80M | 1070.90M | 19.20M | -465.40M |
| Free cash flow | 707.90M | 704.20M | 539.00M | 558.70M | 7.00M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| RHC Ramsay Health Care Ltd |
-0.26 0.46% |
55.75 | 41.18 | 31.85 | 0.69 | 2.57 | 1.25 | 11.44 |
| RHCPA Ramsay Health Care Ltd |
-0.05 0.05% |
106.81 | 65.76 | - | 0.77 | - | - | - |
| REG Regis Healthcare Ltd |
-0.07 1.38% |
5.01 | 28.22 | 28.90 | 1.14 | 259.34 | 0.99 | 4.39 |
| RYM Ryman Healthcare Limited |
- -% |
1.44 | - | - | 1.71 | 0.70 | 6.49 | - |
| SNZ Summerset Group Holdings Ltd |
-0.16 3.09% |
5.02 | 4.80 | 5.25 | 3.15 | 0.46 | 18.77 | 19.38 |
Ramsay Health Care Limited owns and operates hospitals in Australia, the United Kingdom, France, and the Nordics. It offers services in various therapeutic areas, such as cardiology, oncology, orthopaedics, and mental health. The company also provides hospital in the home and telehealth services; and clinical specialties to private and self-insured patients, and patients referred by the NHS, as well as operates health clinics and pharmacy retail franchise network. It offers health care services to public and private patients. The company was founded in 1964 and is based in St Leonards, Australia.
Level 7, Tower B, St Leonards, NSW, Australia, 2065
61 2 9433 3444
91400
| Name | Title | Year Born |
|---|---|---|
| Mr. Craig Ralph McNally | CEO, MD & Exec. Director | 1961 |
| Mr. Martyn J. Roberts | Group Chief Financial Officer | 1968 |
| Ms. Kelly Hibbins | Group Head of Investor Relations | NA |
| Ms. Henrietta Rowe BECON, L.L.B. | Group Gen. Counsel & Company Sec. | NA |
| Ms. Colleen Harris | Group Chief People Officer | 1969 |
| Mr. Andrew Wearne | Global Chief Audit Exec. | NA |
| Dr. Andrew Jones | Group Chief Growth Officer | 1974 |
| Sir Edward Byrne AC, DSc, FMEDSCI, FRACP, FRCP, FTSE, M.D., MBA | Group Chief Medical Officer | 1952 |
| Mr. Kah Peng Hong | Group Chief Exec. Officer of Ramsay Sime Darby Health Care | 1973 |
| Doug Meagher | CFO of Ramsay Australia | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.